DRAFT - Confidential current levels of capability. All provinces have been allocated management <strong>and</strong> administrative support in relation to their <strong>plan</strong>ned number of sites. Provinces with more limited resources at present have also been allocated further staff to ensure that implementation can be driven <strong>for</strong>ward effectively. All provinces have been allocated a non-staff budget to support day-to-day programme management activities, <strong>and</strong> to fund limited local communications activities. Table 16.17: Provincial Programme Management–Personnel Budget (R<strong>and</strong>s) Provinces 2003/04 2004/05 2005/06 onward Eastern Cape 895,092 7,336,554 9,782,072 Free State 639,351 3,740,204 4,986,939 Gauteng 799,189 5,898,014 7,864,019 KwaZulu-Natal 1,118,864 7,336,554 9,782,072 Limpopo 895,092 7,336,554 9,782,072 Mpumalanga 895,092 5,898,014 7,864,019 Northern Cape 639,351 3,740,204 4,986,939 North West 735,254 7,336,554 9,782,072 Western Cape 799,189 5,178,744 6,904,992 Total 7,416,473 53,801,396 71,735,195 Table 16.18: Provincial Programme Management–Non-Personnel Budgets (R<strong>and</strong>s) Provinces 2003/04 2004/05 2005/06 onward Eastern Cape 723,773 3,834,139 4,445,518 Free State 659,838 2,935,051 3,246,735 Gauteng 699,797 3,474,504 3,966,005 KwaZulu-Natal 779,716 3,834,139 4,445,518 Limpopo 723,773 3,834,139 4,445,518 Mpumalanga 723,773 3,474,504 3,966,005 Northern Cape 659,838 2,935,051 3,246,735 North West 683,813 3,834,139 4,445,518 Western Cape 699,797 3,294,686 3,726,248 Total 6,354,118 31,450,349 35,933,799 Chapter XVI: Budget 255
DRAFT - Confidential Table 16.19: Total Provincial Programme Management Budget (R<strong>and</strong>s) Provinces 2003/04 2004/05 2005/06 onwards Eastern Cape 1,618,864 11,170,693 14,227,590 Free State 1,299,189 6,675,255 8,233,673 Gauteng 1,498,986 9,372,518 11,830,023 KwaZulu-Natal 1,898,581 11,170,693 14,227,590 Limpopo 1,618,864 11,170,693 14,227,590 Mpumalanga 1,618,864 9,372,518 11,830,023 Northern Cape 1,299,189 6,675,255 8,233,673 North West 1,419,067 11,170,693 14,227,590 Western Cape 1,498,986 8,473,430 10,631,240 Total 13,770,591 85,251,745 107,668,993 Summary of Budget Requirements The total budget requirements <strong>for</strong> this programme are estimated below (Table 16.20). Table 16.20: Total Programme Budget Estimate (Millions of R<strong>and</strong>s) 2003/04 2004/05 2005/06 2006/07 2007/08 Service Staff 21 322 432 662 1,027 Laboratory Testing 20* 152 311 520 806 Antiretroviral Drugs 42 369 725 1,118 1,650 Nutrition 63 343 421 532 656 Health System Capability Upgrading 70 171 184 160 160 Programme Management (National <strong>and</strong> Provincial) 16 103 128 128 128 Capital Investment 30 75 100 100 0 Research 34 55 55 48 48 Total 296 1,590 2,358 3,268 4,474 * Includes R20 million advance payment to NHLS Sensitivities The Task Team sees the following sensitivities in its estimates. Savings are likely in the budget as laboratory costs are reduced through efficiencies <strong>and</strong> nutrition costs are reduced through more aggressive price negotiations. In the last two years of the budget, the Task Team assumes a higher proportion of the eligible people accessing ARVs than is typical internationally. In the first two <strong>and</strong> a half years, the Task Team assumes a gradual build up to the proportions (Table 16.1). If a higher proportion of eligible people access ARVs in the first few years, it is possible that the cost of the programme will be as much as 10%, or, in the extreme, 20% higher than in the budget summary during 2004/05 <strong>and</strong> 2005/06. Chapter XVI: Budget 256
- Page 1 and 2:
OPERATIONAL PLAN FOR COMPREHENSIVE
- Page 3 and 4:
LIST OF TABLES Table 0.1: Total Pro
- Page 5 and 6:
LIST OF ACRONYMS ADR AIDS ALT API A
- Page 7 and 8:
Foreword I would like to thank the
- Page 9 and 10:
We hope that all South Africans who
- Page 11 and 12:
16. Dr. Fazel Randera, Health Advis
- Page 13 and 14:
Executive Summary BACKGROUND 1. The
- Page 15 and 16:
6. Following the discussion of this
- Page 17 and 18:
health status and to prolong life),
- Page 19 and 20:
extreme inequalities and disparitie
- Page 21 and 22:
9.5 Providing a Comprehensive Conti
- Page 23 and 24:
efforts through additional investme
- Page 25 and 26:
elements in a containment strategy
- Page 27 and 28:
18. The programme detailed in this
- Page 29 and 30:
monitoring of patients for TB, a co
- Page 31 and 32:
40 The drug procurement strategies
- Page 33 and 34:
follow-up and monitoring for patien
- Page 35 and 36:
CHAPTER III - TRADITIONAL MEDICINE
- Page 37 and 38:
74 The minimum service point accred
- Page 39 and 40:
85. Task Team projections of AIDS p
- Page 41 and 42:
patented and/or branded drugs suppl
- Page 43 and 44:
102. It proposes a significant expa
- Page 45 and 46:
measure the outcomes of the program
- Page 47 and 48:
119. Examples of specific research
- Page 49 and 50:
Table 0.1: Total Programme Budget E
- Page 51 and 52:
the existing health care system and
- Page 53 and 54:
Table 0.2: New Patients Starting AR
- Page 55 and 56:
DRAFT - Confidential Chapter I Prev
- Page 57 and 58:
DRAFT - Confidential The key preven
- Page 59 and 60:
DRAFT - Confidential practitioners,
- Page 61 and 62:
DRAFT - Confidential 6. Levels of C
- Page 63 and 64:
DRAFT - Confidential Patients seen
- Page 65 and 66:
DRAFT - Confidential c. Adult ARV D
- Page 67 and 68:
DRAFT - Confidential increased freq
- Page 69 and 70:
DRAFT - Confidential first few week
- Page 71 and 72:
DRAFT - Confidential development of
- Page 73 and 74:
DRAFT - Confidential evidence, nevi
- Page 75 and 76:
DRAFT - Confidential their lives. A
- Page 77 and 78:
DRAFT - Confidential point of conta
- Page 79 and 80:
DRAFT - Confidential ADMINISTRATIVE
- Page 81 and 82:
DRAFT - Confidential joint collabor
- Page 83 and 84:
DRAFT - Confidential reduces the po
- Page 85 and 86:
DRAFT - Confidential Coordination w
- Page 87 and 88:
DRAFT - Confidential Chapter III Tr
- Page 89 and 90:
DRAFT - Confidential In addition to
- Page 91 and 92:
DRAFT - Confidential Development of
- Page 93 and 94:
DRAFT - Confidential SPECIAL CONSID
- Page 95 and 96:
DRAFT - Confidential SECTION TWO HU
- Page 97 and 98:
DRAFT - Confidential collaboration
- Page 99 and 100:
DRAFT - Confidential effectiveness)
- Page 101 and 102:
DRAFT - Confidential 18. A system i
- Page 103 and 104:
DRAFT - Confidential Chapter V Huma
- Page 105 and 106:
DRAFT - Confidential • ARV treatm
- Page 107 and 108:
DRAFT - Confidential Table 5.3: Cor
- Page 109 and 110:
DRAFT - Confidential Table 5.5: Tot
- Page 111 and 112:
DRAFT - Confidential forward, the e
- Page 113 and 114:
DRAFT - Confidential The general ch
- Page 115 and 116:
DRAFT - Confidential • ARV treatm
- Page 117 and 118:
DRAFT - Confidential Human Resource
- Page 119 and 120:
DRAFT - Confidential met. These bur
- Page 121 and 122:
DRAFT - Confidential capacity in ma
- Page 123 and 124:
DRAFT - Confidential will be streng
- Page 125 and 126:
DRAFT - Confidential 4. Explore cha
- Page 127 and 128:
DRAFT - Confidential ADMINISTRATIVE
- Page 129 and 130:
DRAFT - Confidential Chapter VI PRO
- Page 131 and 132:
DRAFT - Confidential Table 6.3 list
- Page 133 and 134:
DRAFT - Confidential Laboratories N
- Page 135 and 136:
DRAFT - Confidential Table 6.1: Fac
- Page 137 and 138:
DRAFT - Confidential Table 6.2: Pro
- Page 139 and 140:
DRAFT - Confidential prevalences, t
- Page 141 and 142:
DRAFT - Confidential Table 6.3: Sit
- Page 143 and 144:
DRAFT - Confidential SECTION THREE
- Page 145 and 146:
DRAFT - Confidential generic produc
- Page 147 and 148:
DRAFT - Confidential Fourthly, the
- Page 149 and 150:
DRAFT - Confidential Security of Su
- Page 151 and 152:
DRAFT - Confidential SPECIAL CONSID
- Page 153 and 154:
DRAFT - Confidential manufacturer.
- Page 155 and 156:
DRAFT - Confidential • Management
- Page 157 and 158:
DRAFT - Confidential delivery, the
- Page 159 and 160:
DRAFT - Confidential Pharmacies at
- Page 161 and 162:
DRAFT - Confidential • The Pharma
- Page 163 and 164:
DRAFT - Confidential as a contingen
- Page 165 and 166:
DRAFT - Confidential the first five
- Page 167 and 168:
DRAFT - Confidential • Improving
- Page 169 and 170:
DRAFT - Confidential Johannesburg.
- Page 171 and 172:
DRAFT - Confidential Infant diagnos
- Page 173 and 174:
DRAFT - Confidential SECTION FOUR C
- Page 175 and 176:
DRAFT - Confidential Chapter X Soci
- Page 177 and 178:
DRAFT - Confidential • Clear guid
- Page 179 and 180:
DRAFT - Confidential communities, a
- Page 181 and 182:
DRAFT - Confidential Care and Suppo
- Page 183 and 184:
DRAFT - Confidential The communicat
- Page 185 and 186:
DRAFT - Confidential SECTION FIVE I
- Page 187 and 188:
DRAFT - Confidential The systems sh
- Page 189 and 190:
DRAFT - Confidential and location o
- Page 191 and 192:
DRAFT - Confidential should enable
- Page 193 and 194:
DRAFT - Confidential The Cluster of
- Page 195 and 196:
DRAFT - Confidential or services. O
- Page 197 and 198:
DRAFT - Confidential Monitoring of
- Page 199 and 200:
DRAFT - Confidential The majority o
- Page 201 and 202:
DRAFT - Confidential Comparable rol
- Page 203 and 204:
DRAFT - Confidential Chapter XIII P
- Page 205 and 206: DRAFT - Confidential drug-food inte
- Page 207 and 208: DRAFT - Confidential Antimicrobial
- Page 209 and 210: DRAFT - Confidential PROGRAMME ASSE
- Page 211 and 212: DRAFT - Confidential agenda: to con
- Page 213 and 214: DRAFT - Confidential South African
- Page 215 and 216: DRAFT - Confidential AIDS in South
- Page 217 and 218: DRAFT - Confidential There has been
- Page 219 and 220: DRAFT - Confidential • What is th
- Page 221 and 222: DRAFT - Confidential HIV infection
- Page 223 and 224: DRAFT - Confidential • Determinat
- Page 225 and 226: DRAFT - Confidential Research Overs
- Page 227 and 228: DRAFT - Confidential SECTION SIX MA
- Page 229 and 230: DRAFT - Confidential continual revi
- Page 231 and 232: DRAFT - Confidential The work of th
- Page 233 and 234: DRAFT - Confidential Figure 15.3: C
- Page 235 and 236: DRAFT - Confidential continuous pro
- Page 237 and 238: DRAFT - Confidential Finally, mecha
- Page 239 and 240: DRAFT - Confidential protocols. The
- Page 241 and 242: DRAFT - Confidential Table 16.1: Es
- Page 243 and 244: DRAFT - Confidential required for t
- Page 245 and 246: DRAFT - Confidential and consumable
- Page 247 and 248: DRAFT - Confidential will also allo
- Page 249 and 250: DRAFT - Confidential Table 16.8: Pl
- Page 251 and 252: DRAFT - Confidential Table 16.11: T
- Page 253 and 254: DRAFT - Confidential mechanisms to
- Page 255: DRAFT - Confidential Table 16.16: S
- Page 259 and 260: DRAFT - Confidential Given the cons
- Page 261 and 262: DRAFT - Confidential month follow-u